![]() Studies aimed at both preventing the disease in at-risk pre-Type 1 subjects as well as intervening not only in new-onset cases, but also in established disease have been conducted over the past 30 years. Changing the course of the disease by preventing or slowing down beta cell destruction rather than managing hyperglycemia would significantly impact the burden. Glycemic targets both in children (and adolescents especially) as well as adults are met only by a minority of patients. ![]() Type 1a (autoimmune) diabetes remains a tremendous burden both to individuals and society. ![]() DOI: 10.1089/dia.2016.2525ĭEVELOPING DISEASE-MODIFYING THERAPIES IN CHILDREN WITH TYPE 1 DIABETES Abstracts from ATTD 2016 9th International Conference on Advanced Technologies & Treatments for DiabetesĭIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Supplem© Mary Ann Liebert, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
September 2023
Categories |